Financhill
Back

4D Molecular Therapeutics Vs. Cytokinetics Industry Stock Comparison

Sell
44

FDMT
4D Molecular Therapeutics

Last Price:
25.74
Seasonality Move:
-0.46%
Sell
39

CYTK
Cytokinetics

Last Price:
59.38
Seasonality Move:
13%
Sell
44
4D Molecular Therapeutics (FDMT) is a Sell

Is 4D Molecular Therapeutics a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics [FDMT] share price is $25.57. The Score for FDMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $57.89. The Score for CYTK is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics's stock price today?

  • The 4D Molecular Therapeutics share price today is $25.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $57.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 45.76 Sell
Chaikin Money Flow: -384368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.51 - 26.83) Sell
Bollinger Bands (100): (20.52 - 30.14) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.98 Sell
Relative Strength Index (14 RSI): 29.3 Sell
Chaikin Money Flow: -1709553 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.43 - 70.29) Sell
Bollinger Bands (100): (61.06 - 84.26) Sell

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.18 Sell
20-day SMA: 25.37 Buy
50-day SMA: 28.05 Sell
200-day SMA: 19.6 Buy
8-day EMA: 25.79 Sell
20-day EMA: 26 Sell
50-day EMA: 26.41 Sell
200-day EMA: 21.96 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.66 Sell
20-day SMA: 64.84 Sell
50-day SMA: 67.18 Sell
200-day SMA: 52.9 Buy
8-day EMA: 62.76 Sell
20-day EMA: 64.82 Sell
50-day EMA: 67.15 Sell
200-day EMA: 58.02 Sell

4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.20 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.61 per share.

4D Molecular Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):